OBJECTIVE: To study the bioavailability of domestic and imported telmisartan tablets and evaluate its bioequivalence in healthy volunteers. METHODS: A single oral dose of 80 mg domestic and imported telmisartan tablets was given to 24 healthy male volunteers according to an open randomized 2 way crossover design. The plasma concentration of telmisartan was determined by a HPLC assay. RESULTS: The pharmacokinetic parameters of the two products were as follows: tmax (0.82 ± 0.33) and (0.81 ± 0.20) h, ρmax (560.94 ± 229.23) and (602.75 ± 212.71) μg·L-1, AUC0-t (3 231.42 ± 1 353.49) and (3 304.46 ± 1 308.97) μg·h·L-1, respectively. The relative bioavailability of domestic product was (98.2 ± 11.5) %. CONCLUSION: Two preparations were bioequivalence.